US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 15.140
  • +0.150+1.00%
Close May 7 16:00 ET
  • 15.150
  • +0.010+0.07%
Post 17:27 ET
1.79BMarket Cap24.03P/E (TTM)

About Catalyst Pharmaceuticals Company

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Company Profile

SymbolCPRX
Company NameCatalyst Pharmaceuticals
Listing DateNov 8, 2006
Issue Price6.00
Founded2002
CEOMr. Richard J. Daly
MarketNASDAQ
Employees167
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address355 Alhambra Circle,Suite 801
CityCoral Gables
ProvinceFlorida
CountryUnited States of America
Zip Code33134
Phone1-305-420-3200
Websitehttp://www.catalystpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard J. Daly
  • Director, President and Chief Executive Officer
  • 14.08M
  • Brian Elsbernd, J.D.
  • Chief Compliance Officer and Chief Legal Officer
  • --
  • Dr. Preethi Sundaram, PhD
  • Chief Strategy Officer
  • --
  • Jeffrey Del Carmen
  • Executive Vice President and Chief Commercial Officer
  • 2.51M
  • Dr. Steven R. Miller,PhD
  • Executive Vice President, Chief Operating Officer and Chief Scientific Officer
  • 3.40M
  • Michael W. Kalb
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Gary Ingenito,M.D.,PhD
  • Chief Medical and Regulatory Officer
  • 2.37M
  • Patrick J. McEnany
  • Non-Executive Chairman of the Board
  • 2.15M
  • Molly Harper
  • Independent Director
  • 363.12K
  • Charles B. O'Keeffe
  • Lead Independent Director
  • 397.24K
  • Donald A. Denkhaus
  • Independent Director
  • 376.24K
  • Dr. David S. Tierney,M.D.
  • Independent Director
  • 370.99K
  • Tamar Thompson
  • Independent Director
  • 610.43K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg